CAS: 509077-99-0 - Ertumaxomab
Formula:Unspecified
- Sinonimi:
- Immunoglobulin G2a, anti-(human HER-2/neu) (mouse monoclonal 2502A/TP-A-02/TPBs03 heavy chain), disulfide with mouse monoclonal 2502A/TP-A-02/TPBs03 light chain, disulfide with immunoglobulin G2b, anti-(human CD3 (antigen)) (rat monoclonal 26/II/6-1.2/TPBs03 heavy chain), disulfide with rat monoclonal 26/II/6-1.2/TPBs03 light chain
- Immunoglobulin G2a, anti-(human neu (receptor)) (mouse monoclonal 2502A/TP-A-02/TPBs03 heavy chain), disulfide with mouse monoclonal 2502A/TP-A-02/TPBs03 light chain, disulfide with immunoglobulin G2b, anti-(human CD3 (antigen)) (rat monoclonal 26/II/6-1.2/TPBs03 heavy chain), disulfide with rat monoclonal 26/II/6-1.2/TPBs03 light chain
- Immunoglobulin G2a, anti-(human c-erbB2 (receptor)) (mouse monoclonal 2502A/TP-A-02/TPBs03 heavy chain), disulfide with mouse monoclonal 2502A/TP-A-02/TPBs03 light chain, disulfide with immunoglobulin G2b, anti-(human CD3 (antigen)) (rat monoclonal 26/II/6-1.2/TPBs03 heavy chain), disulfide with rat monoclonal 26/II/6-1.2/TPBs03 light chain
- Ertumaxomab
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | Ertumaxomab REF: 3D-CLA1169CAS: 509077-99-0 | - - - | Prezzo su richiesta | Lun 16 Dic 24 |
Ertumaxomab
CAS:509077-99-0
Anti-human CD22 recombinant antibody bispecific antibody targeting HER2/neu and CD3.
Ref: 3D-CLA1169
| Dimensione non definita | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Lunedì 16 Dicembre 2024
